These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6225621)

  • 1. Contact sensitivity to betamethasone 17-valerate and fluocinolone acetonide.
    Pasricha JS; Gupta R
    Contact Dermatitis; 1983 Jul; 9(4):330-1. PubMed ID: 6225621
    [No Abstract]   [Full Text] [Related]  

  • 2. Cushing's syndrome induced by topical steroids used for the treatment of non-bullous ichthyosiform erythroderma.
    Borzyskowski M; Grant DB; Wells RS
    Clin Exp Dermatol; 1976 Dec; 1(4):337-42. PubMed ID: 793745
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioral dermatitis, an important side-effect of corticosteroids.
    Weber G
    Dermatologica; 1976; 152 Suppl 1():161-72. PubMed ID: 133839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
    Shimao S
    J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
    [No Abstract]   [Full Text] [Related]  

  • 6. DOUBLE-BLIND COMPARATIVE TRIAL OF BETAMETHASONE 17-VALERATE AND FLUOCINOLONE ACETONIDE OINTMENTS.
    BUCKLEY DB
    J Ir Med Assoc; 1964 Aug; 55():45-7. PubMed ID: 14179703
    [No Abstract]   [Full Text] [Related]  

  • 7. Iatrogenic dermatitis.
    Sneddon I
    Br Med J; 1969 Oct; 4(5674):49. PubMed ID: 4241782
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID.
    WILLIAMS DI; WILKINSON DS; OVERTON J; MILNE JA; MCKENNA WB; LYELL A; CHURCH R
    Lancet; 1964 May; 1(7344):1177-9. PubMed ID: 14132653
    [No Abstract]   [Full Text] [Related]  

  • 10. Contact allergic reaction to valerate esters of betamethasone and hydrocortisone.
    Koch EM
    Contact Dermatitis; 1985 Jan; 12(1):58. PubMed ID: 3979047
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosacea-like dermatitis: contraindication or intolerance reaction to strong steroids.
    Weber G
    Br J Dermatol; 1972 Mar; 86(3):253-9. PubMed ID: 4259710
    [No Abstract]   [Full Text] [Related]  

  • 12. BETAMETHASONE 17-VALERATE: A CLINICAL TRIAL OF A NEW TOPICAL STEROID.
    MITCHELL DM; HEANY SH; EAKINS TS
    J Ir Med Assoc; 1964 Aug; 55():44-5. PubMed ID: 14179702
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of resistant psoriasis with topical corticosteroids and dimethylsulfoxide.
    Kaidbey KH
    Dermatologica; 1976; 152(5):316-20. PubMed ID: 955230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reaction to a topical steroid transferred by physical contact.
    Stankler L; Bewsher PD
    Br Med J; 1978 Aug; 2(6134):399-400. PubMed ID: 567511
    [No Abstract]   [Full Text] [Related]  

  • 15. Preservative activity in diluted corticosteroid creams.
    Hugo WB; Denyer SP; York HL; Tucker JD
    J Hosp Infect; 1984 Sep; 5(3):329-33. PubMed ID: 6208253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norwegian scabies following topical steroid therapy.
    Clayton R; Farrow S
    Postgrad Med J; 1975 Sep; 51(599):657-9. PubMed ID: 1197167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment of dermatitis herpetiformis with betamethasone-17-valerate and fluocinolone acetonide.
    Björnberg A; Hellgren L
    Acta Allergol; 1966; 21(6):471-2. PubMed ID: 5333683
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses.
    Afzelius HW; Jacobsen KU
    J Int Med Res; 1979; 7(5):411-4. PubMed ID: 387495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal iatrogenic Cushing's syndrome.
    Nathan AW; Rose GL
    Lancet; 1979 Jan; 1(8109):207. PubMed ID: 84219
    [No Abstract]   [Full Text] [Related]  

  • 20. Diprosone (betamethasone dipropionate) Creame 0-05%. Review and report of a multicentre study.
    Chambers WB; Cash WS; Marinaccio A
    J Int Med Res; 1976; 4(3 Suppl):1-26. PubMed ID: 799993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.